Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FLT3 in human hematologic malignancies.

Leukemia & lymphoma - 1 Aug 2002

Kiyoi Hitoshi, Naoe Tomoki

Abstract excerpt

FLT3, a member of the receptor tyrosine kinase (RTK) class III, is preferentially expressed on the surface of a high proportion of acute myeloid leukemia (AML) and B-lineage acute lymphocytic leukemia (ALL) cells in addition to hematopoietic stem cells, brain, placenta and liver. An interaction of FLT3 and its ligand has been shown to play an important role in the survival, proliferation and differentiation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzoquinones
Share to fms-Like Tyrosine Kinase 3
Share to Lactams, Macrocyclic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Proto-Oncogene Proteins

Share to Quinones

Share to Receptor Protein-Tyrosine Kinases

Share to Tandem Repeat Sequences

Source

Identifiers

PMID: 12400596
DOI: 10.1080/1042819021000002866

Genes

FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FLT3 in human hematologic malignancies.PMID 12400596Read ↗

Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation.Semantic proximity Read ↗

Clinical significance of FLT3 in leukemia.Semantic proximity Read ↗

FLT3 mutations in acute myeloid leukemia.Semantic proximity Read ↗

FLT3 Mutations in Acute Myeloid Leukemia: Unraveling the Molecular Mechanisms and Implications for Targeted TherapiesSemantic proximity Read ↗

FLT3-ITD and its current role in acute myeloid leukaemia.Semantic proximity Read ↗

Targeting FLT3 mutations in AML: review of current knowledge and evidenceSemantic proximity Read ↗

Current knowledge about FLT3 gene mutations, exploring the isoforms, and protein importance in AML.Semantic proximity Read ↗

Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemiaSemantic proximity Read ↗

FLT3 and its role in the pathogenesis of acute myeloid leukaemia.Semantic proximity Read ↗

Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia.Semantic proximity Read ↗

The roles of FLT3 in hematopoiesis and leukemia.Semantic proximity Read ↗

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.